The 6th Annual Psychedelic Therapeutics & Drug Development Conference 2026

The 6th Annual Psychedelic Therapeutics and Drug Development Conference will take place on February 26-27, 2026, in New Orleans, Louisiana. This event brings together leading researchers and leaders from academia, industry, the non-profit sector, and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet medical need. The conference highlights progress being made towards regulatory approval of psychedelics with the potential to treat conditions including inflammatory and autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

The two-day program features speakers and panelists covering topics such as clinical trial design, intellectual property, regulatory guidance, psychedelic drug delivery, commercialization, legal issues, emerging preclinical science, and new clinical data. Conference themes include academic research progress updates, navigating legal challenges in research, targets for novel drug development, fundraising for psychedelic drug programs, psychedelics beyond mental health treatment, biomarkers in psychedelic research, rescheduling and access, research tools and endpoints for psychedelic trials, regulatory challenges and guidance, toxicology studies, due diligence in clinical trial planning, neuroimaging in therapeutic use, reimbursement strategies, the psychedelic patent and IP landscape, optimizing clinical trials, industry data sharing, manufacturing issues, and the fundamental science of psychedelics.

The event has been designed for key stakeholders in this developing field, providing practical guidance, discussion, and networking opportunities. Attendees can network with leading scientists, clinicians, and industry professionals, hear about the latest studies and clinical trials directly from researchers, and discover innovative tools, technologies, and methodologies being developed to advance psychedelic research and therapy. The conference utilizes mobile and web-based platforms to facilitate meetings and connections before, during, and after the event, allowing participants to explore new products and services offered by companies in the psychedelic research space while gaining insights into where the field is headed to inform future research, treatment approaches, and business strategies.